Navigation Links
Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
Date:4/14/2008

e patients:

-- Mild injection site reactions remain the most common side effect

observation.

-- Injection site reactions did not worsen with longer-term dosing and

were not more prevalent in patients who self-administered mipomersen.

-- The incidence and severity of ALT elevations was less in the OLE study

than in the initial studies.

-- The maximal ALT seen in this study was 172 U/L.

-- No patient experienced an elevation of transaminase (ALT) associated

with increased bilirubin (Hy's Law). There were no bilirubins greater

than the upper limit of normal (ULN) observed in any subject.

-- Several patients who experienced increased ALTs either in the OLE

study or in the initial studies continued to receive mipomersen and

experienced decline in ALTs. No patient who experienced increased

ALTs greater than three times the ULN in their initial trial had

increased ALT values when they were retreated with mipomersen in the

OLE study.

"This open-label extension study suggests that mipomersen can be administered with a satisfactory safety profile and continued LDL reductions for prolonged periods of time in patients with familial hypercholesterolemia being treated with maximal doses of statins and other lipid lowering agents," said Evan Stein, M.D., Ph.D., Director, Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio.

Conference Call Information

At 8:30 a.m. Eastern Time Monday, April 14, Isis will conduct a live webcast conference call to discuss mipomersen safety results. Interested parties may access the webcast at http://www.isispharm.com or listen to the call by dialing 877-856-1960. A webcast replay will be available for a limited time.

ABOUT MIPOMERSEN

On January 7, 2008, Isis announced the licensing of mipomersen to Genzyme as
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
2. Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
5. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
6. Anti-Cancer Drug CYT997 Update
7. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
8. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
9. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
10. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
11. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Accuray Incorporated (Nasdaq: ARAY ), ... announced today that the first CyberKnife® Robotic Radiosurgery ... University Hospital of Liege. ,, The University ... of the largest hospitals in Euregio, a cross-country ... a full range of cancer treatments, University Hospital ...
(Date:12/14/2009)... Inc. (Nasdaq: MYL ) today announced that ... Index Dec. 21. Mylan,s common shares will also ... Chairman and CEO Robert J. Coury said: "We ... followed index of leading companies. This development marks ... the rapid growth and strong potential of our ...
(Date:12/14/2009)... The U.S. Food and Drug Administration ... Injectable Suspension for the treatment of schizophrenia in ... LLY ) announced today. ZYPREXA RELPREVV, a long-acting ... up to four weeks. ,, Different from both ... antipsychotics allow for stable concentrations of the active ...
Breaking Medicine Technology:First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3Mylan Added to NASDAQ-100 Index 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 14956 1Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 14956 2Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference 6502 1Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 1Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 2Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 3
... Introduction ,Automation continues to gain importance ... increasing test consolidation, rising demands from clinicians ... shortage of licensed medical technologists. Ultimately, the ... better equipped to meet these modern demands. ...
... Editor ,Since the first system was ... clinical medicine and patient care. During the 1960s, ... blood gases were considered "the most important laboratory ... www.bloodgas.org article by Dr. John Severinghaus, inventor of ...
Other Medicine Technology:Optimizing Quality Control Data Management 2Optimizing Quality Control Data Management 3Optimizing Quality Control Data Management 4Optimizing Quality Control Data Management 5Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 2Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 3Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 4
(Date:12/14/2009)... Dec. 14 When Kurth Krause, an ... instructions for landing on the moon, he,was confident ... anything.,Years later, Kurth realized there was one thing ... kidney transplant and even though dialysis machines,would keep ... a transplant. Kurth,wrote: "My wife is 69 and ...
(Date:12/14/2009)... could be linked to scans performed in 2007 , , ... are exposing patients to far more radiation than previously thought ... cancers a year, two new studies claim. , Based on ... Archives of Internal Medicine , the study authors, joined ... calling on clinicians to limit radiation exposure to patients. , ...
(Date:12/14/2009)... protection, study finds, , , MONDAY, Dec. 14 (HealthDay News) ... their morning without a cup or two of java: ... developing type 2 diabetes. , That,s the conclusion ... coffee you drink, the lower your risk of diabetes. ... percent reduction in the risk of diabetes, the researchers ...
(Date:12/14/2009)... and obesity are linked to an increased risk of ... glargine (a synthetic insulin preparation marketed under the trade ... of certain cancers than other insulins or oral glucose ... control for important factors such as obesity that may ... hand, a large randomized trial designed to examine another ...
(Date:12/14/2009)... to better treatments for asthma, COPD, researchers say , , ... five genetic variants that influence lung function, a finding ... diseases. , The international team of researchers compared lung ... million sites across the human genome in more than ... to the five common genetic variants associated with alterations ...
Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
... the heels of today,s,Human Rights Watch report descrying ... (AHF) today criticized the U.S.,Department of Homeland Security ... well-being of people living with HIV/AIDS in its ... Immigrants,Detained by the U.S.," chronicles the experiences of ...
... Implant Systems,Inc. relocated its global headquarters in ... foot facility. The new facility, located,at 2300 ... newly,formed manufacturing facility and a distribution center. ... and packaging services., The new facility ...
... 7 Free, accurate,information on many neurological ... website from the National Institute of Neurological,Disorders ... Institutes of Health,(NIH). The website is available ... the new website includes publications on,stroke, dementia, ...
... strengthen cells, DNA, animal studies suggest , , FRIDAY, Dec. ... on sunscreens that might someday prevent or treat skin ... to the sun. , Working with hairless mice, researchers ... damage in the tumor-suppressing p53 gene. This type of ...
... Mass., Dec. 7 Smith & Nephew,s,(NYSE: SNN ... as its Senior Vice President of US Sales., ... 20 years experience,in the medical device industry, the last ... sales teams. Over the last decade, he has,served in ...
... 7 Radius Ventures, a health and life,sciences focused ... been named Partner of the firm., "We are ... said Jordan,Davis, Managing Partner of Radius. "David has demonstrated ... are excited to have his,energy and continued contribution as ...
Other Medicine News:Health News:Denial of Care for HIV+ Detainees 'Unacceptable,' Says AHF 2Health News:BioHorizons Expands to New 44,000 Square Foot Facility 2Health News:Gene-Based Sunscreen Might Someday Prevent Skin Cancer 2Health News:Gene-Based Sunscreen Might Someday Prevent Skin Cancer 3Health News:Smith & Nephew Endoscopy Names Todd Usen Senior VP, US Sales 2Health News:Smith & Nephew Endoscopy Names Todd Usen Senior VP, US Sales 3
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: